✨ Your Portfolio is fetched and updated from zerodha.

Biofil Chemicals & Pharmaceuticals Ltd.

BIOFILCHEM

Market Cap
₹97 Cr.
P/E
181.69

Biofil Chemicals & Pharmaceuticals Ltd.

  • Biofil Chem & Pharma
  • Makers Laboratories
  • Bharat Immunological
FAQs on Biofil Chemicals & Pharmaceuticals Ltd. Shareprice

Biofil Chem & Pharma has given lower returns compared to its competitors.
Biofil Chem & Pharma has grown at ~4.2% over the last 2yrs while peers have grown at a median rate of 16.25%

Yes, Biofil Chem & Pharma is expensive.
Latest PE of Biofil Chem & Pharma is 181, while 3 year average PE is 147.
Also latest EV/EBITDA of Biofil Chem & Pharma is 164 while 3yr average is 82.26.

View FAQ's On Business
Growth Table
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Bharat Immunological
Balance Sheet
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Bharat Immunological
Balance Sheet Snapshot
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
*Data is as of latest FY end
Profit & Loss
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Bharat Immunological
Cash Flow
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Bharat Immunological
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
Ratios
= Dominant Factor
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Bharat Immunological
Quarterly Results
  • Biofil Chemicals & Pharmaceuticals Ltd.
  • Makers Laboratories
  • Bharat Immunological
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Biofil Chemicals & Pharmaceuticals Ltd. Financials

Balance sheet of Biofil Chem & Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Biofil Chem & Pharma is increasing.
Latest debt of Biofil Chem & Pharma is ₹0.23 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹4.04 Crs.

The profit is oscillating.
The profit of Biofil Chem & Pharma is ₹0.53 Crs for TTM, ₹0.71 Crs for Mar 2024 and ₹0.56 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Biofil Chem & Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
timeline Timeline
watchlist Watchlist
portfolio Portfolio
alerts Alerts
filter Research
filter Stock Screener
markets Market
raw materials Raw Material
Data feed provided by Accord Fintech